Nuvalent (NUVL) Earnings Date & Reports

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

NUVL is expected to report earnings to fall 4.24% to -112 cents per share on August 07

Q2'25

Est.

$-1.13

Q1'25

Missed

by $0.05

Q4'24

Beat

by $0.03

Q3'24

Missed

by $0.34

Q2'24

Missed

by $0.12

The last earnings report on May 08 showed earnings per share of -117 cents, missing the estimate of -112 cents. With 487.33K shares outstanding, the current market capitalization sits at 5.13B.

View a ticker or compare two or three

Compare

NUVL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For NUVL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for NUVL (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Broadway

Phone

+1 857 357-7000

Employees

Web

https://www.nuvalent.com